Search
Patexia Research
Case number 2:18-cv-01880

H. LUNDBECK A/S et al v. SIGMAPHARM LABORATORIES, LLC > Summary

Court Case Number 2:18-cv-01880

Filing Date May 4, 2018

Termination Date Jul 27, 2018

Court Pennsylvania Eastern District Court

Status Dismissed - Voluntarily

JudgesJuan R. Sanchez

Plaintiff

3

Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals North America

H. Lundbeck A/S

Defendant

Sigmapharm Laboratories, LLC

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
09861630 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment Jan 9, 2018
09227946 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment Jan 5, 2016
08969355 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment Mar 3, 2015
08722684 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment May 13, 2014
08476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors Jul 2, 2013
07144884 Phenyl-piperazine derivatives as serotonin reuptake inhibitors Dec 5, 2006
Menu